Upstream Manufacturing Solutions

  1. Gene Therapy Capabilities For AAV And Lentivirus Production Platforms 3/9/2026

    Get a clear look at the sequential steps behind robust AAV and lentiviral manufacturing, highlighting key process decisions and practical considerations for building reliable gene therapy workflows.

  2. Krakatoa® K500 On-Demand Media And Buffer Manufacturing System 3/4/2026

    Enable co-location of cell culture media and buffer manufacturing and bioproduction with Krakatoa K500, the first bioreactor-scale pod-based manufacturing system. Produce up to 500 liters of sterile solutions on-demand in less than 3 hours.

  3. Krakatoa® K500: The Future Of Media And Buffer Manufacturing 3/2/2026

    Find out how automated pod systems produce up to 500 liters of sterile solutions on-demand, reducing lead times, facility requirements, and quality control burdens in biomanufacturing operations.

  4. Cell Culture Vessels: Closed Systems For High Yield Cell Growth 2/26/2026

    Achieve up to five times the cell growth surface area within a standard footprint. This closed system optimizes yields for stem cells and viral vectors while reducing waste and labor.

  5. Modular Platform For Adherent Cell Culture For Closed Systems 2/26/2026

    Optimize adherent cell expansion with modular, closed-system platforms that provide high surface area, uniform nutrient delivery, and automated perfusion to ensure consistent cellular quality.

  6. ExPERT DTx™ | Electroporation For Discovery And Screening 2/25/2026

    The ExPERT DTx™ empowers you to transfect primary cells and cell lines with minimal perturbation delivering reproducible, high transfection efficiency and cell viability.

  7. NGS AAT For Cell Line Characterization 2/24/2026

    A modern sequencing‑based assay strengthens cell line characterization with greater sensitivity. See how it supports confident, objective safety decisions and helps reduce risk during early development.

  8. Empowering The Future Of Medicine 2/23/2026

    Accelerate from development to commercialization with scalable manufacturing solutions. Integrated digital systems and expert technical advocacy ensure regulatory excellence and rapid batch release.

  9. Ultrafiltration/Diafiltration TFF System For Enhanced Oligo Purification 2/22/2026

    Modernize oligonucleotide manufacturing with robust filtration systems built for hazardous environments. Enhance purity and speed across every batch to ensure reliable and scalable production.

  10. XCell® ATF System 1/23/2026

    Simplify and intensify upstream bioprocessing. The XCell® ATF System, in single-use or stainless steel format, delivers superior cell retention. High impact upstream applications include N-1 perfusion, high productivity harvest, long-term perfusion and seed train intensification.